ARCH Venture Partners IX, LLC
10% Owner
SEC EDGAR ↗10% Owner at Lyell Immunopharma, Inc., filing insider transactions on 2026-11-04.
Total Purchases
$25.0M
1 transaction
Total Sales
—
0 transactions
Companies Traded
1
1 total filings
Active Since
2026-11-04
Last: 2026-11-04
Other Reporting Insiders at Lyell Immunopharma, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-11-04 | LYEL | Purchase | 2.32M | $10.77 | $25.0M | 3.75M | SEC ↗ |
Innovative Cellular Therapeutics Holdings Ltd
ARCH Venture Partners IX, LLC (Lyell Immunopharma, Inc.) Insider Trades | Tormere